Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Freeman

TitleAffiliate
InstitutionUniversity of Colorado Boulder
DepartmentPsych-Psychology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, Fonarow GC, Go AS, Hylek EM, Mahaffey KW, Pokorney SD, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 Jun 06. PMID: 29875139.
      View in: PubMed
    2. O'Brien EC, Holmes DN, Thomas LE, Fonarow GC, Allen LA, Gersh BJ, Kowey PR, Singer DE, Ezekowitz MD, Naccarelli GV, Ansell JE, Chan PS, Mahaffey KW, Go AS, Freeman JV, Reiffel JA, Peterson ED, Piccini JP, Hylek EM. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation. Circulation. 2018 Apr 20. PMID: 29678813.
      View in: PubMed
    3. Friedman DJ, Parzynski CS, Heist EK, Russo AM, Akar JG, Freeman JV, Curtis JP, Al-Khatib SM. Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry. Circulation. 2018 Feb 20. PMID: 29463509.
      View in: PubMed
    4. Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II). J Am Heart Assoc. 2018 Feb 16; 7(4). PMID: 29453305.
      View in: PubMed
    5. Hsu JC, Freeman JV. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review. Clin Pharmacol Ther. 2018 Jan 12. PMID: 29328506.
      View in: PubMed
    6. Ganeshan R, Enriquez AD, Freeman JV. Remote monitoring of implantable cardiac devices: current state and future directions. Curr Opin Cardiol. 2018 Jan; 33(1):20-30. PMID: 29059076.
      View in: PubMed
    7. Inohara T, Shrader P, Pieper K, Blanco RG, Thomas L, Singer DE, Freeman JV, Allen LA, Fonarow GC, Gersh B, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Steinberg BA, Peterson ED, Piccini JP. Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study. JAMA Cardiol. 2018 Jan 01; 3(1):54-63. PMID: 29128866.
      View in: PubMed
    8. Freeman JV, Tabada GH, Reynolds K, Sung SH, Liu TI, Gupta N, Go AS. Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation. Am J Cardiol. 2018 Mar 01; 121(5):602-608. PMID: 29331355.
      View in: PubMed
    9. Barnett AS, Kim S, Fonarow GC, Thomas LE, Reiffel JA, Allen LA, Freeman JV, Naccarelli G, Mahaffey KW, Go AS, Kowey PR, Ansell JE, Gersh BJ, Hylek EM, Peterson ED, Piccini JP. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017 Nov; 10(11). PMID: 29141842.
      View in: PubMed
    10. Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC. Disease understanding in patients newly diagnosed with atrial fibrillation. Heart. 2018 Mar; 104(6):494-501. PMID: 28790169.
      View in: PubMed
    11. Black-Maier E, Kim S, Steinberg BA, Fonarow GC, Freeman JV, Kowey PR, Ansell J, Gersh BJ, Mahaffey KW, Naccarelli G, Hylek EM, Go AS, Peterson ED, Piccini JP. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017 Sep; 40(9):746-751. PMID: 28543401.
      View in: PubMed
    12. Freeman JV, Wang Y, Akar J, Desai N, Krumholz H. National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999-2013. Circulation. 2017 Mar 28; 135(13):1227-1239. PMID: 28148599.
      View in: PubMed
    13. Hess PL, Kim S, Fonarow GC, Thomas L, Singer DE, Freeman JV, Gersh BJ, Ansell J, Kowey PR, Mahaffey KW, Chan PS, Steinberg BA, Peterson ED, Piccini JP. Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation. Am J Med. 2017 Apr; 130(4):449-456. PMID: 27888051.
      View in: PubMed
    14. Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol. 2016 Jun; 9(6). PMID: 27307517; PMCID: PMC4911813 [Available on 06/01/17].
    15. Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Chang P, Peterson ED, Piccini JP. Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):393-402. PMID: 26058720.
      View in: PubMed
    16. Freeman JV, Saxon L. Remote Monitoring and Outcomes in Pacemaker and Defibrillator Patients: Big Data Saving Lives? J Am Coll Cardiol. 2015 Jun 23; 65(24):2611-2613. PMID: 25983010.
      View in: PubMed
    17. Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, Perez MV, Freeman JV, Wang PJ, Heidenreich PA. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015 May; 38(5):285-92. PMID: 25873476; PMCID: PMC4654330.
    18. Holmqvist F, Kim S, Steinberg BA, Reiffel JA, Mahaffey KW, Gersh BJ, Fonarow GC, Naccarelli GV, Chang P, Freeman JV, Kowey PR, Thomas L, Peterson ED, Piccini JP. Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart. 2015 Jun; 101(11):894-9. PMID: 25732748; PMCID: PMC4453487.
    19. Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015 May; 169(5):647-654.e2. PMID: 25965712.
      View in: PubMed
    20. Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58. PMID: 25414270; PMCID: PMC4334705.
    21. Freeman JV, Yang J, Sung SH, Hlatky MA, Go AS. Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes. 2013 Sep 01; 6(5):525-33. PMID: 24021697.
      View in: PubMed
    22. Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC. Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. Am J Med. 2013 Jul; 126(7):625-32.e1. PMID: 23787195; PMCID: PMC4037289.
    23. Chang TI, Yang J, Freeman JV, Hlatky MA, Go AS. Effectiveness of ß-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. J Card Fail. 2013 Mar; 19(3):176-82. PMID: 23482078; PMCID: PMC4126798.
    24. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012 Jan 10; 59(2):143-9. PMID: 22222078.
      View in: PubMed
    25. Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011 Jan 04; 154(1):1-11. PMID: 21041570.
      View in: PubMed
    26. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2010 Sep 28; 56(14):1133-9. PMID: 20863954.
      View in: PubMed
    27. Kweon O, Kim SJ, Freeman JP, Song J, Baek S, Cerniglia CE. Substrate specificity and structural characteristics of the novel Rieske nonheme iron aromatic ring-hydroxylating oxygenases NidAB and NidA3B3 from Mycobacterium vanbaalenii PYR-1. MBio. 2010 Jun 15; 1(2). PMID: 20714442; PMCID: PMC2921158.
    28. Sutherland JB, Heinze TM, Pearce MG, Deck J, Williams AJ, Freeman JP. Biotransformation of acridine by Mycobacterium vanbaalenii. Environ Toxicol Chem. 2009 Jan; 28(1):61-4. PMID: 18717621.
      View in: PubMed
    29. Kweon O, Kim SJ, Jones RC, Freeman JP, Adjei MD, Edmondson RD, Cerniglia CE. A polyomic approach to elucidate the fluoranthene-degradative pathway in Mycobacterium vanbaalenii PYR-1. J Bacteriol. 2007 Jul; 189(13):4635-47. PMID: 17449607; PMCID: PMC1913438.
    30. Williams AJ, Deck J, Freeman JP, Paul Chiarelli M, Adjei MD, Heinze TM, Sutherland JB. Biotransformation of flumequine by the fungus Cunninghamella elegans. Chemosphere. 2007 Feb; 67(2):240-3. PMID: 17123578.
      View in: PubMed
    31. Kim SJ, Kweon O, Jones RC, Freeman JP, Edmondson RD, Cerniglia CE. Complete and integrated pyrene degradation pathway in Mycobacterium vanbaalenii PYR-1 based on systems biology. J Bacteriol. 2007 Jan; 189(2):464-72. PMID: 17085566; PMCID: PMC1797382.
    32. Freeman JV, Dewey FE, Hadley DM, Myers J, Froelicher VF. Autonomic nervous system interaction with the cardiovascular system during exercise. Prog Cardiovasc Dis. 2006 Mar-Apr; 48(5):342-62. PMID: 16627049.
      View in: PubMed
    33. Moody JD, Freeman JP, Cerniglia CE. Degradation of benz[a]anthracene by Mycobacterium vanbaalenii strain PYR-1. Biodegradation. 2005 Dec; 16(6):513-26. PMID: 15865344.
      View in: PubMed
    34. Brezna B, Kweon O, Stingley RL, Freeman JP, Khan AA, Polek B, Jones RC, Cerniglia CE. Molecular characterization of cytochrome P450 genes in the polycyclic aromatic hydrocarbon degrading Mycobacterium vanbaalenii PYR-1. Appl Microbiol Biotechnol. 2006 Jul; 71(4):522-32. PMID: 16317545.
      View in: PubMed
    35. Kim YH, Freeman JP, Moody JD, Engesser KH, Cerniglia CE. Effects of pH on the degradation of phenanthrene and pyrene by Mycobacterium vanbaalenii PYR-1. Appl Microbiol Biotechnol. 2005 Apr; 67(2):275-85. PMID: 15592827.
      View in: PubMed
    36. Moody JD, Freeman JP, Fu PP, Cerniglia CE. Degradation of benzo[a]pyrene by Mycobacterium vanbaalenii PYR-1. Appl Environ Microbiol. 2004 Jan; 70(1):340-5. PMID: 14711661; PMCID: PMC321301.
    37. Moody JD, Fu PP, Freeman JP, Cerniglia CE. Regio- and stereoselective metabolism of 7,12-dimethylbenz[a]anthracene by Mycobacterium vanbaalenii PYR-1. Appl Environ Microbiol. 2003 Jul; 69(7):3924-31. PMID: 12839762; PMCID: PMC165122.
    Freeman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)